Journal of Controlled Release 2015

7 papers
In 2015, the Journal of Controlled Release published research centered on multi-functional delivery systems for oncology and immunology. A prominent theme was the co-delivery of therapeutic agents, such as combining doxorubicin with siRNA or all-trans-retinoic acid to address drug resistance and target cancer stem cells. Investigations into stimuli-responsive materials were also featured, including temperature-sensitive nanogels for transarterial chemoembolization and ultrasound-responsive nanobubbles for breast cancer imaging and treatment. Research from this year also explored the structural stability and evaluation of various nanocarriers, including silk fibroin nanoparticles, block copolymer micelles, and dendrimer-complexed hydrogels for local paclitaxel delivery. Additionally, the journal highlighted developments in vaccine technology through the study of lymphatic-targeted cationic liposomes designed to enhance immunological memory. Prolific authors contributing to these areas included Jingjing Hu, Qing Zhang, and Yiyao Liu. These studies collectively reflect a focus on improving the precision of local delivery and the biological performance of complex polymer-based carriers in biological media.

Papers

Title
Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
Co-delivery of doxorubicin and P-gp siRNA into human breast cancer cells by functionalized PLGA nanobubbles and ultrasound imaging in vitro
Dendrimer complexed hydrogel for local delivery of PTX to inhibit recurrence of breast cancer
General considerations regarding the in vitro and in vivo properties of block copolymer micelle products and their evaluation
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
The stability of silk fibroin nanoparticles coated with cationic polymers in biological media
The studies about doxorubicin-loaded p(N-isopropyl-acrylamide-co-butyl methylacrylate) temperature-sensitive nanogel dispersions on the application in TACE therapies for rabbit VX2 liver tumor